Altimmune, Inc. (ALT)
2.855
-0.06
(-2.23%)
USD |
NASDAQ |
May 15, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
Altimmune EPS Diluted (Quarterly) : -0.1813 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| Amgen, Inc. | 3.344 |
| Verastem, Inc. | -0.3723 |
| Karyopharm Therapeutics, Inc. | -1.236 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.56M |
| Total Expenses (Quarterly) | 22.56M |
| Enterprise Value | 259.49M |
| Earnings Yield | -32.84% |
| Normalized Earnings Yield | -32.84 |